Literature DB >> 23769735

The U-box-type ubiquitin ligase PRP19β regulates astrocyte differentiation via ubiquitination of PTP1B.

Takeyuki Yamada1, Yumiko Urano-Tashiro, Yoshimi Hashi, Marimu Sakumoto, Hirotada Akiyama, Fumio Tashiro.   

Abstract

U-box protein PRP19β, a splicing variant of PRP19α, suppresses neuronal differentiation and conversely promotes astrocyte differentiation as a neuron/glia switch molecule. However, the mechanistic basis of PRP19β in astrocyte differentiation is not well understood. Here, we demonstrated that PRP19β regulates the stability of protein tyrosine phosphatase 1B (PTP1B) via ubiquitination during N(6),2'-O-dibutyryl cyclic AMP (cAMP)-induced astrocyte differentiation of C6 cells. Only overexpression of PRP19β conferred astrocyte properties at a certain level, and induced more astrocyte markers, glial fibrillary acidic protein (GFAP) and S100β, in the presence of cAMP, whereas its down-regulation by antisense RNA showed a suppressive effect. In addition, ectopic expression of PRP19β led to robust phosphorylation of signal transducer and activator of transcription 3 (STAT3) accompanying the reduction in PTP1B stability during astrocyte differentiation. Immunological analysis revealed that PRP19β interacted with PTP1B and ubiquitinated PTP1B via its U-box region. Forced expression of the U-box deletion mutant of PRP19β resulted in inhibition of astrocyte differentiation. Moreover, down-regulation of PTP1B by short hairpin (sh)RNA enhanced astrocyte differentiation, while forced expression of PTP1B showed an inhibitory effect. Thus, these results indicate that PRP19β activates the gp130/Janus kinase (JAK)/STAT signaling pathway during astrocyte differentiation of C6 cells via PTP1B ubiquitination.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Astrocyte differentiation; CHX; GAPDH; GFAP; IL-6; JAK; Janus kinase; N(6),2-O-dibutyryl cyclic AMP; Neuron/glia switch; PRP19β; PTP1B; RA; SHP2; STAT3; Src homology domain 2 (SH2)-containing protein phosphatase; Ub; Ubiquitination; WB; Western blotting; cAMP; cycloheximide; glial fibrillary acidic protein; glyceraldehyde 3′-phosphate dehydrogenase; interleukin-6; pSTAT3; phosphorylated STAT3; protein tyrosine phosphatase 1B; retinoic acid; signal transducer and activator of transcription 3; ubiquitin

Mesh:

Substances:

Year:  2013        PMID: 23769735     DOI: 10.1016/j.brainres.2013.06.007

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  A U-Box Type E3 Ubiquitin Ligase Prp19-Like Protein Negatively Regulates Lipid Accumulation and Cell Size in Chlamydomonas reinhardtii.

Authors:  Qiulan Luo; Hui Zhu; Chaogang Wang; Yajun Li; Xianghui Zou; Zhangli Hu
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 6.064

Review 2.  The role of targeted protein degradation in early neural development.

Authors:  Banu Saritas-Yildirim; Elena M Silva
Journal:  Genesis       Date:  2014-03-27       Impact factor: 2.487

3.  Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation.

Authors:  Jian Zheng; Xudong Huang; Wen Tan; Dianke Yu; Zhongli Du; Jiang Chang; Lixuan Wei; Yaling Han; Chengfeng Wang; Xu Che; Yifeng Zhou; Xiaoping Miao; Guoliang Jiang; Xianjun Yu; Xianghong Yang; Guangwen Cao; Chaohui Zuo; Zhaoshen Li; Chunyou Wang; Siu Tim Cheung; Yongfeng Jia; Xiongwei Zheng; Hongbing Shen; Chen Wu; Dongxin Lin
Journal:  Nat Genet       Date:  2016-05-23       Impact factor: 38.330

4.  Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?

Authors:  Marcelo N N Vieira; Natalia M Lyra E Silva; Sergio T Ferreira; Fernanda G De Felice
Journal:  Front Aging Neurosci       Date:  2017-01-31       Impact factor: 5.750

5.  A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.

Authors:  Zhefan Stephen Chen; Xiaoying Huang; Kevin Talbot; Ho Yin Edwin Chan
Journal:  Cell Death Dis       Date:  2021-02-02       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.